Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | 3 | M-CSF | 356.0 | 41 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 309.0 | 69 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | M-CSF | 322.0 | 51 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 321.0 | 46 | ||||
RA1869 | 3 | M-CSF | 326.5 | 34 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 474.0 | 47 | ||||
N2759 | 3 | M-CSF | 523.5 | 46 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 362.0 | 41 | ||||
RA1931 | 3 | M-CSF | 379.5 | 54 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 307.0 | 45 | ||||
N2586 | 3 | M-CSF | 324.0 | 46 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 233.0 | 27 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 307.0 | 45 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 484.0 | 49 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 518.0 | 47 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 401.0 | 47 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 362.0 | 51 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 298.5 | 48 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 293.5 | 52 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 358.0 | 40 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 411.0 | 42 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 865.0 | 43 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 596.0 | 26 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 458.0 | 39 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 470.0 | 43 |